$569.51
0.47% yesterday
Nasdaq, Nov 12, 10:04 pm CET
ISIN
US05464C1018
Symbol
AXON

Axon Enterprise Inc Target price 2025 - Analyst rating & recommendation

Axon Enterprise Inc Classifications & Recommendation:

Buy
89%
Hold
11%

Axon Enterprise Inc Price Target

Target Price $895.05
Price $569.51
Potential 57.16%
Number of Estimates 20
20 Analysts have issued a price target Axon Enterprise Inc 2026 . The average Axon Enterprise Inc target price is $895.05. This is 57.16% higher than the current stock price. The highest price target is $1,050.00 84.37% , the lowest is $670.74 17.78% .
A rating was issued by 27 analysts: 24 Analysts recommend Axon Enterprise Inc to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Axon Enterprise Inc stock has an average upside potential 2026 of 57.16% . Most analysts recommend the Axon Enterprise Inc stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027


Dec '24 2025
Estimates
Revenue Billion $ 2.08 2.77
33.44% 33.01%
EBITDA Margin 5.36% 25.25%
56.43% 370.89%
Net Margin 18.10% 19.39%
60.74% 7.10%

23 Analysts have issued a sales forecast Axon Enterprise Inc 2025 . The average Axon Enterprise Inc sales estimate is $2.8b . This is 8.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $2.9b 14.54% , the lowest is $2.6b 1.53% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $2.1b 33.44%
2025 $2.8b 33.01%
2026 $3.4b 24.44%
2027 $4.2b 21.99%

20 Analysts have issued an Axon Enterprise Inc EBITDA forecast 2025. The average Axon Enterprise Inc EBITDA estimate is $700m . This is 3,892.75% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $752m 4,190.18% , the lowest is $658m 3,653.88% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $112m 41.87%
2025 $700m 526.43%
2026 $898m 28.39%
2027 $1.1b 27.93%

EBITDA Margin

2024 5.36% 56.43%
2025 25.25% 370.89%
2026 26.06% 3.21%
2027 27.32% 4.83%

22 Axon Enterprise Inc Analysts have issued a net profit forecast 2025. The average Axon Enterprise Inc net profit estimate is $537m . This is 108.92% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $647m 151.67% , the lowest is $453m 76.24% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $377m 114.49%
2025 $537m 42.47%
2026 $629m 17.08%
2027 $779m 23.94%

Net Margin

2024 18.10% 60.74%
2025 19.39% 7.10%
2026 18.24% 5.93%
2027 18.54% 1.64%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027


Dec '24 2025
Estimates
Earnings Per Share $ 4.80 6.84
106.01% 42.50%
P/E 83.62
EV/Sales 16.14

22 Analysts have issued a Axon Enterprise Inc forecast for earnings per share. The average Axon Enterprise Inc EPS is $6.84 . This is 109.17% higher than earnings per share in the financial year 2024. The highest EPS forecast is $8.24 151.99% , the lowest is $5.77 76.45% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $4.80 106.01%
2025 $6.84 42.50%
2026 $8.01 17.11%
2027 $9.93 23.97%

P/E ratio

Current 174.98 60.42%
2025 83.62 52.21%
2026 71.42 14.59%
2027 57.63 19.31%

Based on analysts' sales estimates for 2025, the Axon Enterprise Inc stock is valued at an EV/Sales of 16.14 and an P/S ratio of 16.30 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 17.48 7.81%
2025 16.14 7.65%
2026 12.97 19.64%
2027 10.63 18.03%

P/S ratio

Current 17.65 7.89%
2025 16.30 7.66%
2026 13.10 19.64%
2027 10.74 18.03%

Current Axon Enterprise Inc Upgrades & Downgrades

Analyst Rating Action Date
Barclays
Overweight
Overweight
Unchanged Nov 06 2025
Piper Sandler
Overweight
Overweight
Unchanged Nov 05 2025
Goldman Sachs
Buy
Buy
Unchanged Nov 05 2025
UBS
Neutral
Neutral
Unchanged Nov 05 2025
JMP Securities
Market Outperform
Market Outperform
Unchanged Sep 29 2025
Needham
Buy
Buy
Unchanged Sep 24 2025
Piper Sandler
Overweight
Initiated Sep 24 2025
Analyst Rating Date
Unchanged
Barclays:
Overweight
Overweight
Nov 06 2025
Unchanged
Piper Sandler:
Overweight
Overweight
Nov 05 2025
Unchanged
Goldman Sachs:
Buy
Buy
Nov 05 2025
Unchanged
UBS:
Neutral
Neutral
Nov 05 2025
Unchanged
JMP Securities:
Market Outperform
Market Outperform
Sep 29 2025
Unchanged
Needham:
Buy
Buy
Sep 24 2025
Initiated
Piper Sandler:
Overweight
Sep 24 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today